About CenExel AMRI
CenExel AMRI is a Healthcare company based in Toms River (United States) founded in 2013, and was acquired by CenExel in September 2021. Research and care for memory loss concerns are provided. It operates on a Professional Services model. CenExel AMRI offers products and services including Clinical Trials for Alzheimer’s Disease, Vaccine Studies, and Healthy Volunteer Studies. Its focus areas include Clinical Research and Alzheimer’s and Dementia Studies. Its legal entity is CenExel Clinical Research.
Company details
Clinical research services are offered by CenExel AMRI, focusing on Alzheimers disease, dementia, and vaccine studies. Operations are conducted in the healthcare sector, with specialized trials for memory loss and cognitive impairments. Innovative medical treatments are provided through clinical trials overseen by board-certified physicians. A state-of-the-art facility in Toms River, United States, is maintained to ensure participant safety and comfort. Solutions for sponsors and CROs are also supported through a dedicated research network.
- Headquarters Toms River, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website amrinj.com
- Social LinkedIn X Facebook
- Acquired by CenExel (Sep 2021)
- Legal Name Cenexel Clinical Research
Products & Services of CenExel AMRI
CenExel AMRI offers a comprehensive portfolio of products and services, including Clinical Trials for Alzheimer’s Disease, Vaccine Studies, and Healthy Volunteer Studies.
Clinical trials for Alzheimer’s are conducted for research.
Vaccine effects against viruses are evaluated through studies.
Healthy volunteer trials are conducted for medical research.
Investors in CenExel AMRI
CenExel AMRI has secured backing from 1 investor. Prominent investors backing the company include CenExel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Research site management and patient recruitment services are provided. | 2019 | cenexelresearch.com | Salt Lake City, United States |
Investor details for CenExel AMRI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of CenExel AMRI
2 dated milestones of CenExel AMRI across 8 years, from founding to its latest funding, stage changes and deals.
- Founded CenExel AMRI is founded.
- Exit Acquired by CenExel.
Top companies in Clinical Trials & Research Tech
3 companies that operate in the same segment as CenExel AMRI (Clinical Trials & Research Tech) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 619.8 M | 252 | ||
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | 22 | ||
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | 25 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about CenExel AMRI
CenExel AMRI was founded in 2013.
CenExel AMRI is headquartered in Toms River, United States. It is registered at Toms River, New Jersey, United States.
Clinical research services are offered by CenExel AMRI, focusing on Alzheimers disease, dementia, and vaccine studies. Operations are conducted in the healthcare sector, with specialized trials for memory loss and cognitive impairments. Innovative medical treatments are provided through clinical trials overseen by board-certified physicians. A state-of-the-art facility in Toms River, United States, is maintained to ensure participant safety and comfort. Solutions for sponsors and CROs are also supported through a dedicated research network.
CenExel AMRI offers Clinical Trials for Alzheimer’s Disease, Vaccine Studies, and Healthy Volunteer Studies.
CenExel AMRI has 1 investor. Key investors include CenExel.
CenExel AMRI operates through Cenexel Clinical Research.
Yes. CenExel AMRI was acquired by CenExel in September 2021.